Standardizing training for Pressurized Intraperitoneal Aerosol Chemotherapy.

[1]  M. Hübner,et al.  Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. , 2019, The Lancet. Oncology.

[2]  K. Soo,et al.  Biphasic learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:technical competence and refinement of patient selection , 2018, Pleura and peritoneum.

[3]  C. Tempfer,et al.  How to Perform Safe and Technically Optimized Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Experience After a Consecutive Series of 1200 Procedures , 2018, Journal of Gastrointestinal Surgery.

[4]  D. Pezet,et al.  Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  C. Tempfer,et al.  Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer , 2018, Archives of Gynecology and Obstetrics.

[6]  Y. Ko,et al.  Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons , 2018, World Journal of Surgical Oncology.

[7]  O. Glehen,et al.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video) , 2018, Journal of Gastrointestinal Surgery.

[8]  N. Demartines,et al.  Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis , 2017, The British journal of surgery.

[9]  J. Esquivel,et al.  Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons , 2017, Annals of surgical oncology.

[10]  N. Demartines,et al.  Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study , 2017, Gastroenterology research and practice.

[11]  N. Demartines,et al.  Postoperative ileus: in search of an international consensus on definition, diagnosis, and treatment , 2017, Langenbeck's Archives of Surgery.

[12]  C. Giacomantonio,et al.  Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. , 2015, Current oncology.

[13]  T. Grantcharov,et al.  Contemporary management of paraesophaegeal hernias: establishing a European expert consensus , 2015, Surgical Endoscopy.

[14]  Charles K. Cooper,et al.  Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials , 2014, Drug Safety.

[15]  Urs Giger-Pabst,et al.  Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy , 2013, Annals of Surgical Oncology.

[16]  E. Kennedy,et al.  Physicians' awareness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer carcinomatosis. , 2013, Canadian journal of surgery. Journal canadien de chirurgie.

[17]  W. Solass,et al.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.

[18]  N. Petrelli,et al.  Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States , 2013, Annals of Surgical Oncology.

[19]  W. Solass,et al.  Description of a novel approach for intraperitoneal drug delivery and the related device , 2011, Surgical Endoscopy.

[20]  David W. Taggart,et al.  No surgical innovation without evaluation: the IDEAL recommendations , 2009, The Lancet.